Indoco Remedies Ltd - INDOCO REMEDIES Share Price

Sector: Pharmaceuticals | ISIN: INE873D01024
₹ 376.60 (4.22%) icon22 Feb, 2024, 12:00:00 AM
Open
₹ 360.35
Prev. Close
₹ 361.35
Turnover(lac)
₹ 0.00
Day's High
₹ 380.75
Day's Low
₹ 358.20
52 Wk High
₹ 415.00
52 Wk Low
₹ 306.40
Book Value
₹ 120.03
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 3,470.38
P/E
31.33
EPS
11.99
Div. Yield
0.60

Indoco Remedies Ltd Stock View

info icon
Edit Image
Target | 02 Feb, 2024 384 (6.27%)

Indoco Remedies Limited is an India-based manufacturer of pharmaceutical products. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and activ... Read More

Indoco Remedies Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/22/2024 12:00:00 AM

    ₹ 376.6 15.25 4.22
  • Open
  • ₹ 360.35
  • Prev. Close
  • ₹ 361.35
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 380.75
  • Day's Low
  • ₹ 358.2
  • 52 Week's High
  • ₹ 415
  • 52 Week's Low
  • ₹ 306.4
  • Book Value
  • ₹ 120.03
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 3,470.38
  • P/E
  • 31.33
  • EPS
  • 11.99
  • Divi. Yield
  • 0.6

Indoco Remedies Ltd Corporate Actions

10 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 Jan , 2024

12:00 AM

06 Oct , 2023

12:00 AM

06 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Aug , 2023

12:00 AM

AGM

Announcement date: 28 Aug , 2023

View Details

23 May , 2023

12:00 AM

Dividend

Dividend amount: 2.25
Announcement date: 23 May , 2023

View Details

14 Jul , 2023

12:00 AM

14 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Sep , 2023

12:00 AM

BookCloser

View Details

Indoco Remedies Ltd News and Update

Image not found
  • 11 hours ago |
  • 12:06 AM

Think and Learn Pvt Ltd, the company that owns Byju's, is accused of breaking India's foreign exchange rules

Image not found
Image not found
  • IIFL News Service |
  • 16 February, 2024 |
  • 11:57 PM
Article Image

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Indoco Remedies Ltd SHAREHOLDING SNAPSHOT
23 February , 2024 | 12:02 AM

PROMOTER - TOTAL58.74%

Indian: 58.74%

Foreign: 0%

NON-PROMOTER - TOTAL 41.26%

Institutions: 21.25%

Non-Institutions: 20.00%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Indoco Remedies Ltd FINANCIALS

Indoco Remedies Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Indoco Remedies Ltd

  • Suresh G Kare
  • Chairman & Wholetime Director
  • Aditi Kare Panandikar
  • Managing Director
  • Sundeep V Bambolkar
  • Joint Managing Director
  • Rajiv Kakodkar
  • Independent Non Exe. Director
  • D M Gavaskar
  • Independent Non Exe. Director
  • Vasudha V Kamat
  • Independent Non Exe. Director
  • Abhijit Y Gore
  • Independent Non Exe. Director
  • Anand Nadkarni
  • Non Executive Director
  • Ajay Mulgaokar
  • Additional Director
  • Satish Shenoy
  • Additional Director

Summary

Indoco Remedies Limited, incorporated as a Public Limited Company in August 23, 1947 is a Mumbai-based pharmaceutical company that focuses on formulations, with some presence in contract manufacturing and research. The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 166 million Company, employs over 6000 people including more than 300 skilled scientists. The Company has 9 manufacturing facilities, 6 of which are for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility.Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal. As per AC Nielsen ORG-MARG market survey (August 2004) of doctors, Indoco ranked first in the stomatology, ninth in the opthalmic and twelve in the pediatric segments in terms of prescription generation in the domestic market. In the overall pharma industry, Indoco is ranked 34th as per AC Nielsen ORG-MARG Retail Audit, but ranked 23rd in terms of prescription generation, indicating the strength of its marketing network. Further, the company last year launched a new super specialty division, with focus on diabetic and cardio-vascular segments. Its entry into the... Read More


Reports by Indoco Remedies Ltd


Reports by Indoco Remedies Ltd

Company FAQ

No Record Found